×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Oxford Biomedica eyes global market amid hawkish trends
BioProcess International
Contract development and manufacturing organization (CDMO) Oxford Biomedica has launched its One OXB strategy in an effort to align its...
3 days ago
Oxford Biomedica Announces Share Capital Update - TipRanks.com
Tipranks
Oxford Biomedica (otc) (GB:OXB) has released an update. Oxford Biomedica, a leading cell and gene therapy CDMO, disclosed that as of April 30, 2024,...
4 days ago
Oxford Biomedica Full Year 2023 Earnings: Misses Expectations
Yahoo Finance AU
Oxford Biomedica ( LON:OXB ) Full Year 2023 Results Key Financial Results Revenue: UK£89.5m (down 36% from FY 2022...
4 days ago
FY2024 Earnings Forecast for Oxford Biomedica plc (OTCMKTS:OXBDF) Issued By Cantor Fitzgerald
Defense World
Read FY2024 Earnings Forecast for Oxford Biomedica plc (OTCMKTS:OXBDF) Issued By Cantor Fitzgerald at Defense World.
1 day ago
Oxford Biomedica shells out 15M euros to acquire ABL Europe
Fierce Pharma
Oxford Biomedica agreed to acquire French CDMO ABL Europe, a subsidiary of Institut Mérieux, for 15 million euros ($16 million) in a deal...
5 months ago
Bullish Oxford Biomedica Insiders Loaded Up On UK£415.3k Of Stock
Simply Wall St
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
4 days ago
Oxford Biomedica confident as it moves away from vaccine era
Sharecast.com
Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on...
6 days ago
Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform
PR Newswire
The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the...
7 months ago
Oxford BioMedica shares soar as vaccine maker raises earnings guidance
Financial Times
The London-listed company, which helped manufacture the Oxford/AstraZeneca vaccine, now expects to break even on operating earnings before...
7 months ago
Oxford Biomedica Expands Global Reach with ABL Europe Acquisition
Contract Pharma
Oxford Biomedica Expands Global Reach with ABL Europe Acquisition. Strengthens its position as a global pure-play cell and gene therapy CDMO...
3 months ago